Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Certified by Founder
Lodge
Antiverse
start up
United Kingdom
- Cardiff, Wales
- 03/03/2023
- Unknown
- $3,000,000
Antiverse is building a world-first computational antibody drug discovery platform. We combine in-house lab expertise with state of the art machine learning to predict antibody-antigen binding and provide antibody drug candidates in weeks.
- Industry Pharmaceutical Manufacturing
- Website https://www.antiverse.io/
- LinkedIn https://www.linkedin.com/company/antiverse/
Related People
Murat TunaboyluFounder
United Kingdom -
Cardiff, Wales
CEO of Antiverse, background in software engineering and bioinformatics. Mid-career developed high-frequency trading systems. After switching to biotech, built cell imaging software and lab robots to accelerate cancer research and automated Thermo Fisher Scientific’s gene synthesis workflows. Co-founded consultancy and biotech companies Svarlight and Antiverse.
Currently focusing on to realise Antiverse’s mission: engineering the future of drug discovery.
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)